Tags

Type your tag names separated by a space and hit enter

Tocilizumab for COVID-19: a real 'miracle drug'?
Infect Dis (Lond). 2020 09; 52(9):681-682.ID

Authors+Show Affiliations

Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.NYU Grossman School of Medicine, New York City, NY, USA.Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.

Pub Type(s)

Letter
Comment

Language

eng

PubMed ID

32644027

Citation

Nasim, Sundus, et al. "Tocilizumab for COVID-19: a Real 'miracle Drug'?" Infectious Diseases (London, England), vol. 52, no. 9, 2020, pp. 681-682.
Nasim S, Hashmi SH, Azim D, et al. Tocilizumab for COVID-19: a real 'miracle drug'? Infect Dis (Lond). 2020;52(9):681-682.
Nasim, S., Hashmi, S. H., Azim, D., Kumar, S., & Nasim, J. (2020). Tocilizumab for COVID-19: a real 'miracle drug'? Infectious Diseases (London, England), 52(9), 681-682. https://doi.org/10.1080/23744235.2020.1780307
Nasim S, et al. Tocilizumab for COVID-19: a Real 'miracle Drug'. Infect Dis (Lond). 2020;52(9):681-682. PubMed PMID: 32644027.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Tocilizumab for COVID-19: a real 'miracle drug'? AU - Nasim,Sundus, AU - Hashmi,Shariq Haider, AU - Azim,Dua, AU - Kumar,Sohail, AU - Nasim,Jasia, Y1 - 2020/06/17/ PY - 2020/7/10/entrez PY - 2020/7/10/pubmed PY - 2020/7/15/medline SP - 681 EP - 682 JF - Infectious diseases (London, England) JO - Infect Dis (Lond) VL - 52 IS - 9 SN - 2374-4243 UR - https://www.unboundmedicine.com/medline/citation/32644027/Tocilizumab_for_COVID_19:_a_real_'miracle_drug' L2 - https://www.tandfonline.com/doi/abs/10.1080/23744235.2020.1780307 DB - PRIME DP - Unbound Medicine ER -